Abnova (Taiwan) Corporation — Investor Relations & Filings
Abnova Corporation is a global leader in the high-throughput production of antibodies and recombinant proteins. By integrating industrial-scale manufacturing with IT-driven management systems, the company maintains one of the world's largest catalogs of biological reagents. Its core offerings encompass gene synthesis, cytogenetics, peptide services, and protein expression. Abnova provides comprehensive solutions for life science research, including custom antibody production, scale-up, and humanization. Recent technological expansions include the RNAutomation™ mRNA service, NanoAb™ services, and nanoCAR-T mRNA solutions. The company supports academic and industrial researchers across multidisciplinary fields with integrated assay development and advanced bioreagent tools.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公告COVID-19病毒萃取試劑組取得美國緊急使用授權(EUA)核准， 可用於臨床實驗室檢測 | 2020-06-16 | Chinese | |
| 本公司簽訂COVID-19治療性抗體人類化合作協議 | 2020-06-11 | Chinese | |
| 109年5月背書保證與資金貸與 | 2020-06-10 | Chinese | |
| 109年5月營業收入 | 2020-06-10 | Chinese | |
| 係因本公司有價證券於集中交易市場達公布注意交易資訊標準， 故公布相關財務業務等重大訊息，以利投資人區別瞭解。 | 2020-06-09 | Chinese | |
| 109年05月董事會成員及持股 | 2020-06-07 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2020
15 filings
| |||||
| 34540871 | 公告COVID-19病毒萃取試劑組取得美國緊急使用授權(EUA)核准， 可用於臨床實驗室檢測 | 2020-06-16 | Chinese | ||
| 34540878 | 本公司簽訂COVID-19治療性抗體人類化合作協議 | 2020-06-11 | Chinese | ||
| 34540887 | 109年5月背書保證與資金貸與 | 2020-06-10 | Chinese | ||
| 34540883 | 109年5月營業收入 | 2020-06-10 | Chinese | ||
| 34540891 | 係因本公司有價證券於集中交易市場達公布注意交易資訊標準， 故公布相關財務業務等重大訊息，以利投資人區別瞭解。 | 2020-06-09 | Chinese | ||
| 34540903 | 109年05月董事會成員及持股 | 2020-06-07 | Chinese | ||
| 34540899 | 109年05月內部人持股異動(事後) | 2020-06-07 | Chinese | ||
| 34540907 | 109年5月13日內部人設質解質 | 2020-05-14 | Chinese | ||
| 34540918 | 109年04月內部人持股異動(事後) | 2020-05-13 | Chinese | ||
| 34540914 | 109年04月董事會成員及持股 | 2020-05-13 | Chinese | ||
| 34540922 | 109年05月僑外投資持股 | 2020-05-12 | Chinese | ||
| 34540925 | 本公司簽訂研發疫苗重要原物料之技術評估協議 | 2020-05-12 | Chinese | ||
| 34540928 | 係因本公司有價證券於集中交易市場達公布注意交易資訊標準， 故公布相關財務業務等重大訊息，以利投資人區別瞭解。 | 2020-05-08 | Chinese | ||
| 34540934 | 109年4月背書保證與資金貸與 | 2020-05-08 | Chinese | ||
| 34540930 | 109年4月營業收入 | 2020-05-08 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
|
ACROBIOSYSTEMS CO.,LTD.
Provides recombinant proteins and reagents for life science…
|
301080 | CN | Professional, scientific and te… |
Abnova (Taiwan) Corporation via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52384/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52384 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52384 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52384 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52384}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Abnova (Taiwan) Corporation (id: 52384)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.